STOCK TITAN

Logos Global Files 13D: 6.3M ARVN Shares, Urges $700M Payout

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Logos Global and affiliated funds report owning a meaningful stake in Arvinas, Inc. The filing shows Logos Global Management and related entities jointly beneficially own 6,300,000 shares, representing 8.6% of Arvinas's outstanding common stock based on 73,417,595 shares. Logos Global Master Fund holds 5,000,000 shares (6.8%) and Logos Opportunities Fund holds 1,300,000 shares (1.8%). Purchases were made on the open market: Global Fund acquired 3,200,000 shares for $23,534,011.75 and exercised 15,000 call options on August 15, 2025 to obtain 1,500,000 shares for $7,500,000; Opportunities Fund acquired 1,300,000 shares for $10,067,317.13. The reporting persons state their purpose is investment but have actively engaged management, recommending a strategic reset including a $700 million return of capital, expense reductions, a 1-for-5 reverse stock split, and refraining from further early-stage pipeline investment absent a strategic partner.

Positive

  • Declared significant stake: Reporting persons collectively hold 6,300,000 shares (8.6% of class).
  • Substantive engagement: Sent detailed recommendations to the board urging a strategic reset and capital return of $700 million.
  • Transparent acquisition details: Disclosed open-market purchases and option exercises including amounts paid ($23,534,011.75; $10,067,317.13; $7,500,000).

Negative

  • Major strategic demands: Recommendation for a $700 million return of capital and 1-for-5 reverse split represent substantial changes to company structure and capital allocation.
  • Potential for active campaign: Filing signals intent to monitor and potentially pursue additional actions, which may lead to significant corporate governance debates.

Insights

TL;DR: Logos Global disclosed an 8.6% position and explicit activist requests for a $700M capital return and structural changes.

Logos Global and affiliated funds accumulated positions through open-market purchases and option exercises, now owning a combined 6.3 million shares (8.6%). The filing documents direct engagement: a June 10 email and an August 7 letter urging a strategic reset focused on returning $700 million, sharply reducing operating expenses, reframing valuation around core science, and executing a 1-for-5 reverse split. Those proposals are material strategic demands that could drive near-term corporate actions or negotiations with the board. The funds state they bought shares for investment but reserve the right to buy or sell and to use derivatives or pledges as needed.

TL;DR: Reporting persons disclose coordinated voting and disposition power and formal recommendations to management and the board.

The filing clarifies control and advisory relationships among the reporting entities and names Dr. William Arsani and Graham Walmsley as control/portfolio managers. Logos Global serves as investment adviser to the Funds and is entitled to management fees and allocations per agreements disclosed. The communication history with the board is explicit and requests significant governance and capital-allocation changes including a reverse split and large shareholder distribution. These communications and the concentrated stake could prompt board consideration under applicable fiduciary processes.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
Percentage based on 73,417,595 shares of Common Stock outstanding as of August 1, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13D


Logos Global Management LP
Signature:/s/ Arsani William
Name/Title:Arsani William. Managing Partner
Date:08/21/2025
Logos Global Management GP LLC
Signature:/s/ Arsani William
Name/Title:Arsani William, Managing Member
Date:08/21/2025
Logos Global Master Fund LP
Signature:/s/ Arsani William
Name/Title:Arsani William, Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:08/21/2025
Logos GP LLC
Signature:/s/ Arsani William
Name/Title:Arsani William, Managing Member
Date:08/21/2025
Logos Opportunities Fund IV GP LLC
Signature:/s/ Arsani Willliam
Name/Title:Arsani William, Managing Member
Date:08/21/2025
Logos Opportunities Fund IV LP
Signature:/s/ Arsani William
Name/Title:Arsani William, Managing Member of Logos Opportunities IV GP LLC, General Partner of Logos Opportunities Fund IV LP
Date:08/21/2025
Arsani William
Signature:/s/ Arsani William
Name/Title:Arsani William, Reporting Person
Date:08/21/2025
Graham Walmsley
Signature:/s/ Graham Walmsley
Name/Title:Graham Walmsley, Reporting Person
Date:08/21/2025

FAQ

How many Arvinas (ARVN) shares do Logos Global and affiliates report owning?

The filing reports Logos Global and affiliated entities beneficially own 6,300,000 shares, equal to 8.6% of Arvinas common stock.

What transactions did Logos Global Master Fund execute to build its position in ARVN?

Global Fund acquired 3,200,000 shares on the open market for $23,534,011.75, purchased and later exercised 15,000 call options to receive 1,500,000 shares for $7,500,000.

What strategic changes did the reporting persons request from Arvinas management?

They recommended a strategic reset urging a $700 million capital return, substantial operating expense reductions, reframing valuation around core science, and a 1-for-5 reverse stock split.

Did the reporting persons claim they are part of a formal group under Schedule 13D?

They state they are filing jointly but explicitly disclaim membership in a group.

What percentage of Arvinas does Logos Opportunities Fund IV hold?

Logos Opportunities Fund IV holds 1,300,000 shares, representing 1.8% of the class.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

761.70M
59.11M
6.85%
94.18%
11.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN